In a meta-analysis 6 of eight trials with 60080 patients (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony Outcomes, REWIND, PIONEER 6, and AMPLITUDE-O) , treatment with a GLP-1 receptor agonist led to a 14% relative risk reduction in three-point MACE (HR 086 [95% CI 080093]
Table of Contents What Is Glucagon-Like Peptide-1 (GLP-1)
Number one: these patients require probably brand name medicines that dont have generic products available in the marketplace and those drugs are expensive and theyre becoming more and more expensive as we get into more rare disease biologic type of therapies
This dual mechanism is what separates tirzepatide from older GLP-1 medications like semaglutide , which only activate the GLP-1 receptor
It acts as an antifoaming agent to break up trapped bubbles and relieve abdominal pressure
M.KaplanL